Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

NCT02451839 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02451839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
July 6, 2015
Completion date
December 5, 2017
Enrollment
168 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, psoriasis, rheumatoid arthritis